Extending SGLT2 Inhibitor Use for People Undergoing Dialysis?

Clin J Am Soc Nephrol. 2023 Aug 1;18(8):991-993. doi: 10.2215/CJN.0000000000000232. Epub 2023 Jul 7.

Authors

Wendy L St Peter¹, Calvin J Meaney²

Affiliations

¹ College of Pharmacy, University of Minnesota, Minneapolis, Minnesota.
² University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, New York.

No abstract available

Publication types

Editorial
Comment

MeSH terms

Diabetes Mellitus, Type 2*
Humans
Hypoglycemic Agents / adverse effects
Renal Dialysis / adverse effects
Sodium-Glucose Transporter 2 Inhibitors* / adverse effects

Substances

Sodium-Glucose Transporter 2 Inhibitors
Hypoglycemic Agents